key: cord-1034293-c8ezpwya
authors: Cerfolio, Robert J.
title: Leveraging Scarcity to Optimize Value and Clinical Operations
date: 2020-06-12
journal: Ann Thorac Surg
DOI: 10.1016/j.athoracsur.2020.06.003
sha: 426494153f03e40ce7cc6d0460fb7797938c95d8
doc_id: 1034293
cord_uid: c8ezpwya

nan

Reply to the Editor:

We appreciate the kind letter from Gursoy and colleagues [1] in reply to our article [2] .

Infrastructure and resources dictate day-to-day clinical operations. There is little doubt that when both of these are limited, they conspire to create obstacles to patient care and workflow. Culture The authors state "in our country, there is no bronchoscopy of every intensive care unit". This is also true for our institution here at New York University (NYU) Langone Health System.

Nor does one need a bronchoscope for each unit. One only needs to figure out how to operationalize having one available for emergencies (obstructed airways from sections) and also available for elective procedures such as a percutaneous tracheostomy.

The authors describe a technique that is essentially identical to ours except they do not use a bronchoscope to help guide the needle entry into the trachea at the 12 o'clock position. The main disadvantage with their technique is that even with palpation and pre-procedure ultrasound one cannot prevent improper tracheal entry. A side tracheostomy often is problematic.

The second disadvantage of their "pause ventilator tracheostomy" technique is the time of apnea. We also have employed "pauses" and periods of apneas in properly selected patients as well. This has been an additional iteration to our percutaneous dilatational tracheostomy technique since publication because we believe it further decreases the risk of spreading viral particles to nearby healthcare workers. The authors report in this series of one patient, that the "paused ventilation lasted for about 41 seconds and the patient did not develop hypoxemia." This may be true in the lone single patient in this series but likely would not be true for the majority of the patients in our experience. Most patients experience significant reduction in their oxygen saturation during any apnea periods of 20 seconds or greater. The clinical import of this may be mild but at times, but it can lead to bradycardia and even significant cardiopulmonary embarrassment.

We congratulate the authors report in this single patient and their innovative strategy secondary to resource scarcity. The key to any procedure is its reproducible, outcomes, durability, value and adoption rates over time in a wide range of patients by a number of physicians from diverse cultures. We await these results. 

Pause Ventilation Tracheostomy

Novel Percutaneous Tracheostomy for Critically Ill Patients with COVID-19